Glycoprotein (GP) IIb/IIIa complex (integrin αIIbß3) is the most abundant platelet receptor. It serves as an inducible receptor for adhesive proteins and is the best-studied member of the integrin family. Its major global structural features have been elucidated mainly during the last decade. Since 1995, there has been a substantial increase in structural information on adhesion molecule domains. The crystal structures of isolated integrin I domains have been solved. Although a high resolution picture of a whole integrin molecule is not yet available, the crystal structures together with biochemical, mutagenesis and modeling data provide a useful framework for interpreting current experimental evidence on structure-function correlations of integrin molecules and for guiding further experiment. The aim of this minireview is to update a previous one summarizing recent (1995-98) functional and structural data of GPIIb/IIIa and other integrins in the perspective of an emerging model of the structure, and bidirectional signaling mechanism through, integrin αIIbß3.
Get full access to this article
View all access options for this article.
References
1.
SchwartzMA, SchallerMD, GinsbergMH. Integrins: Emerging paradigms of signal transduction. Annu Rev Cell Dev Biol11: 549599, 1995.
2.
CamperL, HellmanU, Lundgren-ÅkerlundE. Isolation, cloning, and sequence of the integrin subunit α10, a ß1-associated collagen binding integrin expressed on chondrocytes. J Biol Chem273: 2038320389, 1998.
3.
CalveteJJ. On the structure and function of platelet integrin αIIbß3, the fibrinogen receptor. Proc Soc Exp Biol Med208: 346360, 1995.
4.
De FougerollesA, SpringerTA. Ideas crystallized on immunoglobulin superfamily-integrin interactions. Chem Biol2: 639643, 1995.
5.
ClarkEA, BruggeJS. Integrins and signal transduction pathways: The road taken. Science268: 233239, 1995.
6.
ParsonJT. Integrin-mediated signaling: Regulation by protein tyrosine kinases and small GTP-binding proteins. Curr Opin Cell Biol8: 146152, 1996.
KolanusW, SeedB. Integrins and inside-out signal transduction: Converging signals from PKC and PIP3. Curr Opin Cell Biol9: 725731, 1997.
12.
LaFlammeSE, HomanSM, BodeauAL, MastrangeloAM. Integrin cytoplasmic domains as connectors to the cell's signal transduction apparatus. Matrix Biol16: 153163, 1997.
13.
O'tooleTE. Integrin signaling: Building connections beyond the focal contacts?Matrix Biol16: 165171, 1997.
14.
ClarkEA, KingWG, BruggeJS, SymonsM, HynesRO. Integrin-mediated signals regulated by members of the ρ family of GTPases. J Cell Biol142: 573586, 1998.
PorterJC, HoggN. Integrins take partners: Cross-talk between integrins and other membrane receptors. Trends Cell Biol8: 390396, 1998.
17.
van WilligenG, HersI, GoiterG, AkkermanJW. Exposure of ligand-binding sites on platelet integrin αIIb/ß3 by phosphorylation of the ß3 subunit. Biochem J314: 769779, 1996.
18.
O'tooleTE, YlanneJ, CulleyBM. Regulation of integrin affinity states through an NPXY motif in the ß subunit cytoplasmic domain. J Biol Chem270: 85538558, 1995.
HughesPE, Díaz-GonzálezF, LeongL, WuC, McDonaldJA, ShattilSJ, GinsbergMH. Breaking the integrin hinge: A defined structural constraint regulates integrin signaling. J Biol Chem271: 65716574, 1997.
23.
PeyruchaudO, NurdenAT, MiletS, MacchiL, PannochiaA, BrayPF, KiefferN, BourreF. R to Q amino acid substitution in the GFFKR sequence of the cytoplasmic domain of the integrin αIIb subunit in a patient with Glanzmann's thrombasthenia-like syndrome. Blood92: 41784187, 1998.
24.
HaasTA, PlowEF. The cytoplasmic domain of αIIbß3: A ternary complex of the integrin a and ß subunits and a divalent cation. J Biol Chem271: 60176026, 1996.
25.
HaasTA, PlowEF. Development of a structural model for the cytoplasmic domain of an integrin. Protein Eng10: 13951405, 1998.
26.
MelkerAA, KramerD, KuikmanI, SonnenbergA. The two Phe in the GFFKR motif of the integrin α6A subunit are essential for heterodimerization. Biochem J328: 529537, 1997.
27.
DedharS. Novel functions for calreticulin: Interaction with integrins and modulation of gene expression?Trends Biochem Sci19: 269271, 1994.
28.
IndigFE, Diaz-GonzalezF, GinsbergMH. Analysis of the tetraspanin CD9-integrin αIIbß3 (GPIIb-IIIa) complex in platelet membranes and transfected cells. Biochem J327: 291298, 1997.
29.
NaikUP, PatelPM, PariseLV. Identification of a novel calcium-binding protein that interacts with the αIIb integrin cytoplasmic domain. J Biol Chem272: 46514654, 1997.
30.
EigenthalerM, HöffererL, ShattilSJ, GinsbergMH. A conserved sequence motif in the integrin ß3 cytoplasmic domain is required for its specific interaction with ß3-endonexin. J Biol Chem272: 76937698, 1997.
HumphriesMJ, NewhamP. The structure of cell-adhesion molecules. Trends Cell Biol8: 7883, 1998.
33.
DoolittleRF, EverseSJ, SpraggonG. Human fibrinogen: Anticipating a 3-dimensional structure. FASEB J10: 14641470, 1996.
34.
JonesEY, HarlosK, BottomleyMJ, RobinsonRC, DriscollPC, EdwardsRM, ClementsJM, DudgeonTJ, StuartDI. Crystal structure of an integrin-binding fragment of vascular cell adhesion molecule-1 at 1.8 Å resolution. Nature373: 539544, 1995.
35.
WangJ-H, PepinskyRB, StehleT, LiuJ-H, KarpusasM, BrowningB, OsbomL. The crystal structure of an N-terminal two-domain fragment of vascular cell adhesion molecule 1 (VCAM-1): A cyclic peptide based on the domain 1 C-D loop can inhibit VCAM-1-α4 integrin interaction. Proc Natl Acad Sci U S A92: 57145718, 1995.
36.
TanK, CasasnovasJM, LiuJ-H, BriskinMJ, SpringerTA, WangJ-H. The structure of immunoglobulin superfamily domains 1 and 2 of MadCAM-1 reveals novel features important for integrin recognition. Structure6: 793801, 1998.
37.
CasasnovasJM, StehleT, LiuJ-H, WangJ-H, SpringerTA. A dimeric crystal structure for the N-terminal two domains of intercellular adhesion molecule-1. Proc Natl Acad Sci U S A95: 413449, 1998.
38.
BellaJ, KolatkarPR, MarlorCW, GreveJM, RossmannMG. The structure of the two amino-terminal domains of human ICAM-1 suggests how it functions as a rhinovirus receptor and as an LFA-1 integrin ligand. Proc Natl Acad Sci U S A95: 41404145, 1998.
39.
CasasnovasJM, SpringerTA, LiuJ-H, HarrisonSC, WangJ-H. Crystal structure of ICAM-2 reveals a distinctive integrin recognition surface. Nature387: 312315, 1997.
40.
LeahyDJ, AukhilI, EricksonHP. 2.0-Å crystal structure of a four-domain segment of human fibronectin encompassing the RGD loop and synergy region. Cell84: 155164, 1996.
41.
PetersonJA, VisentinGP, NewmanPJ, AsterRH. A recombinant soluble form of the integrin αIIbß3 (GPIIb-IIIa) assumes an active, ligand-binding conformation and is recognized by GPIIb-IIIa-specific monoclonal, alio-, auto-, and drug-dependent platelet antibodies. Blood92: 20532063, 1998.
42.
LoftusJC, LiddingtonRC. New insights into integrin-ligand interaction. J Clin Invest99: 23022306, 1997.
43.
CalveteJJ. Clues for understanding the structure and function of a prototypic human integrin: The platelet glycoprotein IIb/IIIa complex. Thromb Haemost72: 115, 1994.
44.
DickesonSK, SantoroSA. Ligand recognition by the I domain-containing integrins. Cell Mol Life Sci54: 556566, 1998.
45.
LeeJ-O, RieuP, ArnaoutMA, LiddingtonR. Crystal structure of the A domain from the α subunit of integrin CR3 (CD11b/CD18). Cell80: 631638, 1995.
46.
QuA, LeahyDJ. Crystal structure of the I-domain from the CD11a/CD 18 (LFA-1, αLß2) integrin. Proc Natl Acad Sci U S A92: 1027710281, 1995.
47.
EmsleyJ, KingSL, BergelsonJM, LiddingtonRC. Crystal structure of the I domain from integrin α2ß1. J Biol Chem272: 2851228517, 1997.
BajtML, LoftusJC. Mutation of a ligand-binding domain of ß3 integrin. Integral role of oxygenated residues in αIIbß3 (GPIIb-IIIa) receptor function. J Biol Chem269: 2091320919, 1994.
50.
TakadaY, KamataT, IrieA, Puzon-McLaughlinW, ZhangX-P. Structural basis of integrin-mediated signal transduction. Matrix Biol16: 143151, 1997.
51.
ChenLL, LobbRR, CuervoJH, LinK, AdamsSP, PepinskyRB. Identification of ligand binding sites on integrin α4ß1 through chemical cross-linking. Biochemistry37: 87438753, 1998.
52.
TuckwellDS, HumphriesMJ. A structure prediction for the ligand-binding region of the integrin ß subunit: Evidence for the presence of a von Willebrand factor A domain. FEBS Lett400: 297303, 1997.
53.
TakagiJ, KamataT, MerdithJ, McLaughlinW, TakadaY. Changing ligand specificities of αvß1 and αvß3 integrins by swapping a short diverse sequence of the ß subunit. J Biol Chem272: 1979419800, 1997.
54.
McDowallA, LeitingerB, StanleyP, BatesPA, RandiAM, HoggN. The I domain of integrin leukocyte function-associated antigen-1 is involved in a conformational change leading to high affinity binding to ligand intercellular adhesion molecule 1 (ICAM-1). J Biol Chem273: 2739627403, 1998.
55.
ZhangL, PlowEF. A discrete site modulates activation of I domains: Application to integrin αMß2. J Biol Chem271: 2995329957, 1996.
56.
LoftusJC, HalloranCE, GinsbergMH, FeigenLP, ZablockiJA, SmithJW. The amino-terminal one-third of αIIb defines the ligand recognition specificity of integrin αIIbß3. J Biol Chem271: 20332039, 1996.
57.
BaneresJL, RoquetF, GreenM, LeCalvezH, ParelloJ. The cation-binding domain from the α-subunit of integrin α5ß1 is a minimal domain for fibronectin recognition. J Biol Chem273: 2474424753, 1998.
58.
KamataT, PuzonW, TakadaY. Identification of putative ligand-binding sites of the integrin α4ß1 (VLA-4, CD49d/CD29). Biochem J305: 945951, 1995.
59.
SchifferSG, HemlerME, LobbRR, TizardR, OsbornL. Molecular mapping of functional antibody binding sites of α4 integrin. J Biol Chem270: 1427014273, 1995.
60.
IrieA, KamataT, Puzon-McLaughlinW, TakadaY. Critical amino acid residues for ligand binding are clustered in a predicted ß-turn of the third N-terminal repeat in the integrin α4 and α5 subunits. EMBO J14: 55505556, 1995.
61.
KamataT, IrieA, TokuhiraM, TakadaY. Critical residues of integrin αIlb subunit for binding of αIIbß3 (glycoprotein IIb-IIIa) to fibrinogen and ligand-mimetic antibodies (PAC-1, OP-G2, and LJ-CP3). J Biol Chem271: 1861018615, 1996.
62.
HondaS, TomiyamaY, ShiragaM, TadokoroS, TakamatsuJ, SaitoH, KurataY, MatsuzawaY. A two-amino acid insertion in the Cys146-Cys167 loop of the αIIb subunit is associated with a variant of Glanzmann thrombasthenia: Critical role of Asp 163 in ligand binding. J Clin Invest102: 11831192, 1998.
63.
MouldAP, BurrowsL, HumphriesMJ. Identification of amino acid residues that form part of the ligand-binding pocket of integrin α5ß1. J Biol Chem273: 2566425672, 1998.
64.
PujadesC, AlonR, YauchRL, MasumotoA, BurklyLC, ChenC, SpringerTA, LobbRR, HemlerME. Defining extracellular α-chain sites that affect cell adhesion and adhesion strengthening without altering soluble ligand binding. Mol Biol Cell8: 26472657, 1997.
65.
NiewiarowskaJ, SwiderskaM, MajewskiT, CierniewskiCS. Peplide-specific antibodies as probes of the topography of the Ca2+-binding motifs in αIIbß3. Thromb Haemost78: 15101515, 1997.
66.
WilcoxDA, PaddockCM, LymanS, GillJC, NewmanPJ. Glanzmann thrombasthenia resulting from a single amino acid substitution between the second and third calcium-binding domains of GPIIb. Role of the GPIIb amino terminus in integrin subunit association. J Clin Invest95: 15531560, 1995.
67.
BasaniRB, VilaireG, ShattilSJ, KolodziejMA, BennettJS, PonczM. Glanzmann thombasthenia due to a two-amino acid deletion in the fourth calcium-binding domain of αIIb: Demonstration of the importance of calcium-binding domains in the conformation of αIIbß3. Blood88: 167173, 1996.
68.
PonczM, RifatS, CollerBS, NewmanPJ, ShattilSJ, ParellaT, FortinaP, BennettJS. Glanzmann thrombasthenia secondary to a Gly273→Asp mutation adjacent to the first calcium-binding domain of platelet glycoprotein IIb. J Clin Invest93: 172179, 1994.
69.
StanleyP, BatesPA, HarveyJ, BennettRI, HoggN. Integrin LFA-I α subunit contains an ICAM-1 binding site in domains V and VI. EMBO J13: 17901798, 1994.
70.
SpringerTA. Folding of the N-terminal, ligand-binding region of integrin α-subunits into a ß-propeller domain. Proc Natl Acad Sci U S A94: 6572, 1997.
71.
OxvigC, SpringerTA. Experimental support for a ß-propeller domain in integrin α- subunits and a calcium binding site on its lower surface. Proc Natl Acad Sci U S A95: 48704875, 1998.
72.
HuangC, LuC, SpringerTA. Folding of the conserved domain but not of flanking regions in the integrin ß2 subunit requires association with the α subunit. Proc Natl Acad Sci U S A94: 31563161, 1997.
73.
LuC, OxvigC, SpringerTA. The structure of the ß-propeller domain and C-terminal region of the integrin αM subunit. J Biol Chem273: 1513815147, 1998.
74.
PeretzH, RosenbergN, UsherS, GraffE, NewmanPJ, CollerBS, SeligsohnU. Glanzmann's thrombasthenia associated with deletion-insertion and alternative splicing in the glycoprotein IIb gene. Blood85: 414420, 1995.
75.
DuX, GuM, WeiselJ, NagaswamiC, BennettJS, BowditchR, GinsbergMH. Long-range propagation of conformational changes in integrin αIIbß3. J Biol Chem268: 2308723092, 1993.
76.
WilkinsJA, LiA, NiH, StupackDG, ShenC. Control of ß1 integrin function: Localization of stimulatory epitopes. J Biol Chem271: 30463051, 1996.
77.
FaullRJ, WangJ, LeavesleyDI, PuzonW, RussGR, VestweberD, TakadaY. A novel activating anti-ß1 integrin monoclonal antibody binds to the cysteine-rich repeats in the ß1 chain. J Biol Chem271: 2509925106, 1996.
78.
SimsPJ, GinsbergMH, PlowEF, ShattilSJ. Effect of platelet activation on the conformation of the plasma membrane glycoprotein IIb-IIIa. J Biol Chem266: 73457352, 1991.
79.
CalveteJJ, MannK, SchäferW, Fernandez-LaFuenteR, GuisánJM. Proteolytic degradation of the RGD-binding and the non-RGD-binding conformers of human platelet integrin glycoprotein IIb/IIIa: Clues for identification of regions involved in receptor's activation. Biochem J298: 17, 1994.
80.
TsuchidaJ, UekiS, TakadaY, SaitoY, TakagiJ. The 'ligand-induced conformational change' of α5ß1 integrin: Relocation of α5 subunit to uncover the ß-1 stalk region. J Cell Sci111: 17591766, 1998.
81.
MouldAP, GarrattAN, Puzon-McLaughlinW, TakadaY, HumphriesMJ. Regulation of integrin function: Evidence that bivalent-cation-induced conformational changes lead to unmasking of ligand-binding sites within integrin α5ß1. Biochem J331: 821828, 1998.
82.
LeeJO, BankstonLA, ArnaoutMA, LiddingtonRC. Two conformations of the integrin α-domain (I-domain): A pathway for activation?Structure3: 13331340, 1995.
83.
QuA, LeahyDJ. The role of divalent cation in the structure of the I domain from the CD11a/CD18 integrin. Structure4: 931942, 1996.
84.
BaldwinET, SarverRW, BryantGLJr., CurryKA, FairbanksMB, FinzelBC, GarlickRL, HeinriksonRL, HortonNC, KelleyLL, MildnerAM, MoonJB, MottJE, MutchlerVT, TomichCS, WatenpaughKD, WileyVH. Cation binding to the integrin CD11b I domain and activation model assessment. Structure6: 923935, 1998.
85.
LiR, RieuP, GriffithDL, ScottD, ArnaoutMA. Two functional states of the CD11b α-domain: Correlations with key features of two Mn2+-complexed crystal structures. J Cell Biol143: 15231534, 1998.
86.
YlänneJ, HuuskonenJ, O'tooleTE, GinsbergMH, VirtanenI, GahmbergCG. Mutation of the cytoplasmic domain of the integrin ß3 subunit: Differential effects of cell spreading, recruitment to adhesion plaques, endocytosis, and phagocytosis. J Biol Chem270: 95509557, 1996.
87.
KnezevicI, LeisnerTM, LamC-T. Direct binding of platelet integrin αIIbß3 (GPIIb-IIIa) to talin: Evidence that interaction is mediated through the cytoplasmic domains of both αIIb and ß3. J Biol Chem271: 1641616421, 1996.
88.
LawDA, Nannizzi-AlaimoL, PhillipsDR. Outside-in integrin signal transduction: αIIbß3-(GPIIb-IIIa) tyrosine phosphorylation induced by platelet aggregation. J Biol Chem271: 1081110815, 1996.
89.
TahilianiPD, SinghL, AuerKL, LaFlammeSE. The role of conserved amino acid motifs within the ß3 integrin cytoplasmic domain in triggering focal adhesion kinase phosphorylation. J Biol Chem272: 78927898, 1997.
90.
Schaffner-ReckingerE, GouonV, MelchiorC, PlanconS, KiefferN. Distinct involvement of ß3 integrin cytoplasmic domain tyrosine residues 747 and 759 in integrin-mediated cytoskeletal assembly and phosphorylation signaling. J Biol Chem273: 1262312632, 1998.
91.
PerraultC, MekracheM, SchoevaertD, KiefferN, MelchiorC, WarszawskiJ, BaruchD. Ser 752 mutation to Pro or Ala in the ß3 integrin subunit differentially affects the kinetics of cell spreading to von Willebrand factor and fibrinogen. Cell Adhes Commun6: 335348, 1998.
